1. Document de presse | 2022.10.20

    How SARS-CoV-2 communicates with human cells: mapping molecular contacts

    Although the mechanisms by which SARS-CoV-2 enters host cells are increasingly well documented, the direct molecular interactions between virus and host remain poorly understood. Scientists from the Institut Pasteur, the French National Center for Scientific Research (CNRS), Université Paris Cité, the Institute of Network Biology (INET) Helmholtz Munich, the Donnelly Center for Cellular and...

  2. Fiche maladie | 2015.10.06

    Aspergillosis

    Aspergillosis is a term that refers to any infection caused by fungus (mold) belonging to the genus Aspergillus, whose spores are present in the air and breathed in by people every day. While Aspergillus is entirely harmless for most individuals, the spores can cause various forms of mycosis. The species Aspergillus fumigatus is responsible for more than 80% of human cases of aspergillosis.

  3. News | 2022.03.22

    Ukrainian scientists: offer to join a host laboratory at the Institut Pasteur in Paris

    In view of the ongoing war in Ukraine, the Institut Pasteur is providing funding to host Ukrainian scientists in its research laboratories.

  4. Document de presse | 2021.11.26

    ComCor study: new results on places of infection with SARS-CoV-2 and analysis of the efficacy of messenger RNA vaccines against the Delta variant

    From May 23 to August 13, 2021, the Institut Pasteur, in partnership with the French National Health Insurance Fund (CNAM), Santé publique France and the Ipsos institute, conducted the fourth part of the ComCor epidemiological study on circumstances and places of infection with the SARS-CoV-2 virus in France. The aim of the study was to identify the socio-demographic factors, places visited and...

  5. News | 2020.11.24

    Researchers from Hong-Kong University - Pasteur Research Pole and Institut Pasteur of New Caledonia are winners of the "Pasteur Network Talent Award" 2020.

    «Pasteur Network Talent Award​s» 2020 were presented on Thursday 19 November 2020 to Dr Sophie Valkenburg and Dr Roman Thibeaux by Pr Pierre-Marie Girard, Institut Pasteur vice-president international Affairs and by Prof. Stewart Cole, President of The Institut Pasteur.Due to the COVID-19 pandemic, these awards were presented by videoconference during the 52nd Council of Directors of the...

  6. Document de presse | 2022.03.29

    SARS-CoV-2: neutralization of BA.1 and BA.2 by therapeutic monoclonal antibodies

    The SARS-CoV-2 Omicron BA.1 sublineage has been supplanted in many countries by the BA.2 sublineage. Although Omicron is responsible for less severe forms in the general population, immunocompromised people are still at higher risk of developing severe forms of COVID-19. Several monoclonal antibodies are currently available in clinical practice as a preventive treatment for these patients....

  7. Document de presse | 2022.12.19

    Modelling has evaluated the role of antiviral treatment and vaccination in exiting the Zero-COVID strategy in Wallis and Futuna

    By June 2022, the Wallis and Futuna Islands, a French overseas territory, had successfully implemented a Zero-COVID strategy that significantly reduced the number of SARS-CoV-2 infections. From mid-June 2022, a gradual reopening of the borders was planned. However, the relatively low immunity in the population (due to limited vaccination coverage and the number of previous infections) and the...

  8. News | 2023.02.22

    Collaboration with UCSF QBI: Institut Pasteur establishes presence in USA

    A delegation from the Institut Pasteur will visit San Francisco during the week of February 28 to March 2, 2023, to present a series of events and workshops that will provide an overview of the Institut Pasteur-UCSF QBI partnership (Institut Pasteur-University of California, San Francisco, Quantitative Biosciences Institute). These events will also promote the establishment of a Center of...

  9. News | 2024.06.10

    THE INSTITUT PASTEUR PARTNERS WITH THE NEW EXHIBITION AT THE MUSÉE DES CONFLUENCES IN LYON: "EPIDEMICS, TAKING CARE OF THE LIVING WORLD"

    From April 12, 2024 to February 16, 2025, the Musée des Confluences is hosting "Epidemics, taking care of the living world," an exhibition in which epidemics are viewed as both a biological and social phenomenon. We speak to anthropologist and project manager, Mathilde Gallay-Keller about this exhibition. 

  10. News | 2024.07.04

    How coronavirus HKU1 forces its way into cells

    Scientists have pinpointed the precise binding sites for the virus HKU1 in respiratory cells, providing a detailed picture of the infection mechanism used by the virus. Their findings shed light on other animal species that may host the virus and pave the way for the development of infection-blocking antibodies.

Pages

Back to top